In summary, we have showed that levels of COX-2 are increased in both TCC and RCC derived from urinary tract epithelium as well as gastrointestinal cancer. These results raised the possibility that selective inhibitors of COX-2 may be useful in the prevention or treatment of these diseases.
CITATION STYLE
Hara, S., Kondo, Y., Matsuzawa, I., Hashimoto, Y., Kimura, G., Akimoto, M., & Imura, N. (2002). Expression of cycloxygenase-2 in human bladder and renal cell carcinoma. In Advances in Experimental Medicine and Biology (Vol. 507, pp. 123–126). Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-0193-0_20
Mendeley helps you to discover research relevant for your work.